Observational studyESMO open2025

Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort study.

K Nozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.